Zometa International (Health/Medications)
zometa.com

Description: A website created to inform healthcare providers outside the US Zometa.com is a website created by Novartis Pharma to inform healthcare professionals outside the US on the drug Zometa (zoledronic acid), which is indicated for the prevention of skeletal related events in patients with advanced malignancies involving bone. These malignancies include multiple myeloma, prostate cancer, breast cancer, lung cancer and other solid tumor types

Specializes in: novartis oncology pharma pharmaceutical company zometa international zoledronic acid hypercalcemia

Website owner:

Registrant:
Novartis AG (DOM-1340018)
P.O. Box CH-4002 Basel - - CH
Domain Name: zometa.com
Registrar Name: Markmonitor.com
Registrar Whois: whois.markmonitor.com
Registrar Homepage: http://www.markmonitor.com
Administrative Contact:
Domain Name Group (NIC-14255851) Novartis AG
P.O. Box CH-4002 Basel - - CH
email hidden +41.613243210 Fax- +41.313242935
Technical Contact, Zone Contact:
Domain Name Group (NIC-14255851) Novartis AG
P.O. Box CH-4002 Basel - - CH
email hidden +41.613243210 Fax- +41.313242935
Created on..............: 1998-Nov-18.
Expires on..............: 2007-Nov-17.
Record last updated on..: 2005-Dec-13 05:45:37.
Domain servers in listed order:
DNS1.NOVARTIS.COM 
DNS2.NOVARTIS.COM 
MIA03.DIGEX.COM